These data reveal that the switch in Gαs to Gαi coupling to β2AR under adrenergic stress is an important pathomechanism of FLS hyperplasia in RA and is an effective pharmacological target of the GRK2 inhibitor CP-25 in the treatment of experimental RA. This evidence concerns the gene ADRB2 and rheumatoid arthritis.